Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesSevere relapses after the first infusion of natalizumab in active relapsing-remitting multiple sclerosis
Multiple Sclerosis, 10/09/09
Rinaldi F et al. – The authors describe three patients suffering from a very active form of relapsing–remitting multiple sclerosis (MS), who experienced severe disease worsening, associated with a marked increase in brain inflammation, a few days after the first administration of natalizumab. Relapsing–remitting MS patients having had a recent relapse should be treated with natalizumab only after achieving complete clinical and radiological remission.
Related Articles
Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases
Journal of Neuroimmunology, 11/04/09
Relevance Score: 94%
Analysis of antibody reactivity in paired cerebrospinal fluid and serum of a relapsing remitting multiple sclerosis patient
Autoimmunity, 11/17/09
Relevance Score: 93%
Severe relapses after the first infusion of natalizumab in active relapsing-remitting multiple sclerosis
Multiple Sclerosis, 10/26/09
Relevance Score: 93%
Cochlear implantation in a profoundly deaf patient who also suffers from multiple sclerosis - a case study
Cochlear Implants International, 10/27/09
Relevance Score: 90%
A single-centre, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis
Multiple Sclerosis, 10/01/09
Relevance Score: 90%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Natalizumab treatment in multiple sclerosis: Marked decline of chemokines and cytokines in cerebrospinal fluid
Multiple Sclerosis, 12/11/09
Behavioral Dimensions and Acetylcholinesterase Inhibitor-related Effect in Alzheimer Disease Over Time: A Latent Trajectory Modeling
Cognitive and Behavioral Neurology, 12/11/09
Depression in Parkinson's Disease
Canadian Journal of Neurological Sciences, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor